Medication-Assisted Treatment Is Becoming a Core Jail and Prison Health Issue in New Mexico

Medication-assisted treatment, often called MAT or MOUD when referring specifically to medications for opioid use disorder, has become one of the most important correctional health topics in the United States. In New Mexico, it is no longer just a best practice or a pilot idea. It is now part of the state's correctional policy framework, with deadlines and implementation steps that make the issue especially current as of today, October 16, 2026. The state's rules for correctional settings took effect on September 1, 2024, and they set out a phased approach for county detention facilities and New Mexico Corrections Department facilities. ([srca.nm.gov](https://www.srca.nm.gov/nmac/nmregister/xxxv/8.325.12.html))

For people in jail or prison, MAT can mean the difference between untreated withdrawal, relapse, and overdose risk on one hand, and continuity of care on the other. In New Mexico, the policy direction is clear: correctional facilities are expected to provide treatment for people who were already receiving MAT or MOUD in the community or in a county detention facility before booking, and state prisons are also expected to initiate treatment for qualified individuals with substance use disorder. ([srca.nm.gov](https://www.srca.nm.gov/nmac/nmregister/xxxv/8.325.12.html))

What New Mexico's Rules Require

New Mexico's correctional regulation, Title 8, Chapter 325, Part 12, governs medication-assisted treatment services in correctional settings. The rule says its purpose is to establish guidance and requirements for substance use disorder treatment and reentry services in correctional facilities. It also states that FDA-approved medications should be offered for opioid use disorder, and that the program should include medications approved for substance use disorder treatment and withdrawal management. ([srca.nm.gov](https://www.srca.nm.gov/nmac/nmregister/xxxv/8.325.12.html))

The timeline matters. Under the rule, by December 31, 2025, NMCD-operated correctional facilities were required to provide continuation of MAT or MOUD for individuals already receiving it in the community or in a county detention facility before booking. By June 30, 2026, NMCD-operated correctional facilities were required to initiate MAT or MOUD for qualified individuals diagnosed with substance use disorder. The rule also says that beginning July 1, 2026, current inmates and detainees may request substance use disorder screening at any time during incarceration, including before release. ([srca.nm.gov](https://www.srca.nm.gov/nmac/nmregister/xxxv/8.325.12.html))

That means New Mexico is moving beyond a narrow "continue only" model and toward a broader treatment model inside prisons. In practical terms, this is a major shift for jail and prison health systems because it requires screening, prescribing capacity, monitoring, and coordination with community providers. ([srca.nm.gov](https://www.srca.nm.gov/nmac/nmregister/xxxv/8.325.12.html))

Why MAT Matters in Jails and Prisons

People entering jail or prison often have disrupted access to medications, unstable housing, and high rates of opioid use disorder or other substance use disorders. Without treatment, withdrawal can be severe, and the period after release is especially dangerous because tolerance drops during incarceration. MAT helps reduce cravings and withdrawal symptoms, supports stability, and can improve the chances that someone continues treatment after release. New Mexico's correctional policy explicitly connects treatment with reentry planning, which reflects the reality that incarceration is often only one part of a longer recovery process. ([srca.nm.gov](https://www.srca.nm.gov/nmac/nmregister/xxxv/8.325.12.html))

In New Mexico, the corrections department's 2026 strategic plan says it aims to expand access to MAT with the goal of making it available to all qualified inmates. The department also lists substance use treatment and reentry support as core priorities. That is important because correctional treatment works best when it is not treated as a one-time intervention, but as part of a continuum that includes discharge planning and community follow-up. ([cd.nm.gov](https://www.cd.nm.gov/wp-content/uploads/2026/04/2026-Strategic-Plan-FINAL-ADA-Compliant.pdf))

What Is Happening Inside New Mexico Prisons

The New Mexico Corrections Department reported in its 2025 annual report that it launched a Medication for Opioid Use Disorder pilot program and later expanded methadone maintenance programming. The report says more than 200 individuals participated in the pilot between January and October 2025, and more than 240 individuals participated overall. It also says the department launched an 1115 waiver program at pilot facilities in July 2025 and continued to build billing capabilities. ([cd.nm.gov](https://www.cd.nm.gov/wp-content/uploads/2026/04/Annual-Report-2025-Final.pdf))

NMCD also has a formal policy for MAT/MOUD that was issued on January 9, 2025 and revised on December 29, 2025. That policy is focused on inmates entering NMCD custody who were already receiving MOUD under a qualified medical provider, and it includes chain-of-custody forms for methadone transfers between facilities and from county jails. This suggests the department is building the operational infrastructure needed to manage controlled medications safely across custody settings. ([cd.nm.gov](https://www.cd.nm.gov/wp-content/uploads/2026/01/CD-176300.pdf))

Operationally, that matters because correctional MAT is not just a medical decision. It also involves secure medication storage, documentation, transfer procedures, staff training, and coordination with outside providers. New Mexico's policy and rule language both point to those needs. ([srca.nm.gov](https://www.srca.nm.gov/nmac/nmregister/xxxv/8.325.12.html))

How County Jails Fit Into the Picture

County jails are often the first point of contact with the correctional system, so they play a critical role in MAT access. New Mexico's rule specifically addresses people receiving MAT or MOUD in the community or in a county detention facility before booking, which means county-level continuity is part of the state framework. The NMCD policy also includes a county/jail transfer form for methadone chain of custody, showing that jail-to-prison transitions are being treated as a formal clinical and administrative process. ([srca.nm.gov](https://www.srca.nm.gov/nmac/nmregister/xxxv/8.325.12.html))

For jails, the challenge is often short stays, rapid intake, and limited medical staffing. Even so, the state's direction suggests that jails should not assume treatment can wait until release. Instead, intake screening, verification of existing prescriptions, and referral pathways are becoming essential parts of jail health operations. ([srca.nm.gov](https://www.srca.nm.gov/nmac/nmregister/xxxv/8.325.12.html))

What Makes New Mexico's Approach Distinct

New Mexico stands out because its correctional rules are unusually specific about timelines and treatment expectations. The state is not only encouraging MAT; it is setting deadlines for continuation and initiation inside state facilities. The corrections department's strategic plan also frames MAT as part of a broader effort to improve mental health, substance use, and specialized treatment services. ([srca.nm.gov](https://www.srca.nm.gov/nmac/nmregister/xxxv/8.325.12.html))

Another distinctive feature is the connection between correctional treatment and Medicaid-related infrastructure. The annual report notes the 1115 waiver program at pilot facilities, which suggests the state is trying to align correctional treatment with financing and reentry continuity. That kind of alignment can be important because treatment often fails when the person leaves custody and loses access to medication immediately. ([cd.nm.gov](https://www.cd.nm.gov/wp-content/uploads/2026/04/Annual-Report-2025-Final.pdf))

Key Takeaways for 2026

• New Mexico has a formal correctional rule for MAT/MOUD in jails and prisons, effective September 1, 2024. ([srca.nm.gov](https://www.srca.nm.gov/nmac/nmregister/xxxv/8.325.12.html))
• NMCD facilities were required to continue MAT/MOUD for eligible people by December 31, 2025 and to initiate treatment for qualified individuals by June 30, 2026. ([srca.nm.gov](https://www.srca.nm.gov/nmac/nmregister/xxxv/8.325.12.html))
• Beginning July 1, 2026, inmates and detainees may request substance use disorder screening at any time during incarceration. ([srca.nm.gov](https://www.srca.nm.gov/nmac/nmregister/xxxv/8.325.12.html))
• NMCD reported a MOUD pilot, methadone maintenance expansion, and more than 240 participants in its 2025 annual report. ([cd.nm.gov](https://www.cd.nm.gov/wp-content/uploads/2026/04/Annual-Report-2025-Final.pdf))
• The department's 2026 strategic plan says it aims to expand MAT to all qualified inmates. ([cd.nm.gov](https://www.cd.nm.gov/wp-content/uploads/2026/04/2026-Strategic-Plan-FINAL-ADA-Compliant.pdf))

The Bottom Line

Medication-assisted treatment in New Mexico jails and prisons is now a live policy and operational issue, not a future goal. The state has moved toward a correctional health model that treats substance use disorder as a medical condition requiring screening, medication, continuity of care, and reentry planning. For jails, prisons, families, and community providers, the message is clear: in New Mexico, MAT is becoming part of the standard correctional response to opioid and substance use disorders. ([srca.nm.gov](https://www.srca.nm.gov/nmac/nmregister/xxxv/8.325.12.html))

Other Relevant Articles for New Mexico

Relevant County Info

Information is sourced from publicaly available information and may be inaccurate